![Jacob Glenting](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jacob Glenting
Chief Tech/Sci/R&D Officer at
ALK-ABELLÓ A/S
Profile
Dr. Jacob Glenting is an Independent Director at Qlife Holding AB and an Executive Vice President & Head-Global R&D at ALK-Abello A/S.
He is on the Board of Directors at Qlife Holding AB.
Jacob Glenting active positions
| Companies | Position | Start |
|---|---|---|
| QLIFE HOLDING AB | Director/Board Member | 20/03/2025 |
| ALK-ABELLÓ A/S | Chief Tech/Sci/R&D Officer | 31/08/2026 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
55
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
ALK-Abello A/S
 ALK-Abello A/S Pharmaceuticals: MajorHealth Technology Develops and produces, markets products for diagnosing, treating allergies, allergic asthma & acute anaphylactic reactions | Health Technology |
Qlife Holding AB
 Qlife Holding AB Medical SpecialtiesHealth Technology Manufactures and sells in-vitro diagnostic analysers & reagents | Health Technology |
- Stock Market
- Insiders
- Jacob Glenting
